Q
Qingyi Wei
Researcher at Duke University
Publications - 784
Citations - 36016
Qingyi Wei is an academic researcher from Duke University. The author has contributed to research in topics: Cancer & Single-nucleotide polymorphism. The author has an hindex of 85, co-authored 750 publications receiving 32858 citations. Previous affiliations of Qingyi Wei include Georgetown University Medical Center & Baylor College of Medicine.
Papers
More filters
Journal ArticleDOI
A genetic variant in the APE1/Ref-1 gene promoter -141T/G may modulate risk of glioblastoma in a Chinese Han population.
Keke Zhou,Dezhi Hu,Juan Lu,Weiwei Fan,Hongliang Liu,Hongyan Chen,Gong Chen,Qingyi Wei,Guhong Du,Ying Mao,Daru Lu,Liangfu Zhou +11 more
TL;DR: The results suggest that a specific genetic variant located in the APE1/Ref-1 promoter may modulate risk of glioblastoma, but not for other histological gliomas.
Journal ArticleDOI
Common genetic variation and risk of osteosarcoma in a multi-ethnic pediatric and adolescent population.
Chenan Zhang,Helen M. Hansen,Eleanor C. Semmes,Julio Gonzalez-Maya,Libby M. Morimoto,Qingyi Wei,William C. Eward,Suzanne Bartholf DeWitt,Jillian H. Hurst,Catherine Metayer,Adam J. de Smith,Joseph L. Wiemels,Kyle M. Walsh,Kyle M. Walsh +13 more
TL;DR: Light is shed on the replicability of osteosarcoma risk loci across ethnicities and motivate further characterization of these genetic factors in diverse clinical cohorts.
Journal ArticleDOI
Inverse Relationship between Vitiligo-Related Genes and Skin Cancer Risk.
Journal ArticleDOI
Polymorphisms of MDM4 and risk of squamous cell carcinoma of the head and neck.
TL;DR: It is suggested that the joint effect of MDM4 variants may contribute to the risk of oropharyngeal cancer in non-Hispanic whites.
Journal ArticleDOI
Genetic Susceptibility for Lung Cancer: Interactions with Gender and Smoking History and Impact on Early Detection Policies
Olga Y. Gorlova,Christopher I. Amos,Claudia I. Henschke,Lei Lei,Margaret R. Spitz,Qingyi Wei,Xifeng Wu,Marek Kimmel +7 more
TL;DR: Genetic susceptibility constitutes an important factor in the selection of a high-risk group for early lung cancer detection and is inserted into a model of lung cancer natural history and detection by screening to assess mortality reduction due to screening of high- risk individuals.